KCT0001534终止未知
The efficacy and adverse effect of intralymphatic immunotherapy (ILIT) for allergic diseases
适应症
试验速览
- 阶段
- 未知
- 状态
- 终止
- 入组人数
- 144
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 19(Year) 至 o Limit（—）
- 性别
- All
入选标准
- •Allergic rhinitis to house dust mite (Df, Dp), cat or dog
- •- More than 3mm reaction at skin prick test for Df, Dp, cat or dog
- •or more than class 3 at serum specific IgE level (ImmunoCAP® or multiple allergosorbent test)
排除标准
- •- Uncontrolled or severe asthma according to Global Initiative of Asthma (GINA) guideline
- •- FEV1 less than 50% of predicted value if there is comorbid asthma.
- •- Subject rejects the enrollment into study
- •- Low compliance
- •- Pregnancy or lactation
- •- Significant cardiovascular, hepatic, renal, hematologic, oncologic, or infectious diseases
- •- Administration of beta blocker, angiotensin converting enzyme inhibitor, tricyclic antidepressant, immnosuppressant including systemic glucocorticosteroid (20mg or more dose of prednisolone or equivalent dose of other steroid) within last 2 weeks
- •- Prior history of allergen-specific immunotherapy
- •- Allergic rhinitis caused by other perennial or seasonal allergen
- •- Vulnerable volunteer
研究者
相似试验
招募中
不适用
Intralymphatic immunotherapy with Tyrosine S®, allergen extract for immunotherapyDiseases of th respiratory systemKCT0001777Gachon University40
已完成
2 期
Effects of Intralymphatic Allergen Immunotherapy in treatment of allergic rhinitisIRCT20161206031256N2Vice chancellor for research, Mashhad University of Medical Sciences15
进行中（未招募）
1 期
Effect of intralymphatic immunotherapyMedDRA version: 21.1Level: PTClassification code 10039085Term: Rhinitis allergicSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersMedDRA version: 20.0Level: PTClassification code 10010744Term: Conjunctivitis allergicSystem Organ Class: 10015919 - Eye disordersMedDRA version: 20.0Level: PTClassification code 10003553Term: AsthmaSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersAllergic rhinitisEUCTR2020-001060-28-DKAarhus Universitet528
进行中（未招募）
不适用
Effectiveness and adverse effect of intravenous lacosamide in nonconvulsive status epilepticus and acute repetitive seizures in childreonconvulsive status epilepticus or acute repetitive seizuresIntravenous lacosamideacute repetitive seizuresstatus epilepticusepilepsyTCTR20180508004Phramongkutklao hospital11
进行中（未招募）
1 期
Study with hzVSF-v13 in patients with COVID-19 pneumonia: a phase II, proof of concept, multicentre, randomized, parallel-group, double-blind, placebo-controlled studyModerate-to-severe COVID-19 pneumoniaMedDRA version: 23.0Level: LLTClassification code 10053983Term: Corona virus infectionSystem Organ Class: 100000004862EUCTR2020-003614-13-ITImmuneMed Inc.105